2025
SJR Q3
JCR Q4 · 1,1
8 matched articles
SCIE
Journal detail
Bulletin du Cancer
- Publisher
- John Libbey
- Country
- France · Western Europe
- Type
- journal
- ISSN
-
0007455117696917
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,28
- Quartile Q3
- H-Index 46
- Cites/doc 0,78
- Docs (3y) 536
- Cites (3y) 453
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,1
- 5Y JIF 1,1
- JCI 0,18
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q4
- Hematology Q4
- Medicine (miscellaneous) Q3
- Oncology Q4
- Radiology, Nuclear Medicine and Imaging Q3
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,28 | 1,1 | 1,1 | 0,18 | Q4 | 46 |
| 2024 | Q3 | Q4 | 0,327 | 0,8 | 1 | 0,17 | Q4 | 44 |
| 2023 | Q3 | Q4 | 0,309 | 1,1 | 1 | 0,18 | Q4 | 44 |
| 2022 | Q3 | Q4 | 0,336 | 1,2 | 1,1 | 0,18 | Q4 | 44 |
| 2021 | Q3 | Q4 | 0,284 | 1,3 | 1,2 | 0,21 | Q4 | 44 |
| 2020 | Q3 | Q4 | 0,346 | 1,3 | 1 | 0,2 | Q4 | 44 |
| 2019 | Q3 | Q4 | 0,298 | 0,9 | 0,7 | 0,19 | Q4 | 44 |
| 2018 | — | Q4 | — | 0,7 | 0,6 | 0,19 | Q4 | — |
| 2017 | Q3 | Q4 | 0,219 | 0,8 | 0,6 | 0,18 | Q4 | 44 |
| 2016 | Q3 | Q4 | 0,276 | 0,9 | 0,7 | — | — | 44 |
| 2015 | Q3 | Q4 | 0,291 | 0,7 | 0,6 | — | — | 44 |
| 2014 | Q3 | Q4 | 0,214 | 0,6 | 0,5 | — | — | 44 |
| 2013 | Q3 | Q4 | 0,262 | 0,6 | 0,6 | — | — | 44 |
| 2012 | Q3 | Q4 | 0,23 | 0,6 | 0,5 | — | — | 44 |
| 2011 | Q3 | Q4 | 0,279 | 0,7 | 0,6 | — | — | 44 |
| 2010 | Q3 | Q4 | 0,265 | 0,9 | 0,8 | — | — | 44 |
| 2009 | — | Q4 | — | 0,8 | 0,8 | — | — | — |
| 2008 | — | Q4 | — | 1,1 | 1 | — | — | — |
| 2007 | — | Q4 | — | 0,9 | 0,7 | — | — | — |
| 2006 | — | Q4 | — | 0,9 | — | — | — | — |
| 2005 | — | Q4 | — | 0,8 | — | — | — | — |
| 2004 | — | Q4 | — | 0,7 | — | — | — | — |
| 2003 | — | Q4 | — | 0,7 | — | — | — | — |
| 2002 | — | Q4 | — | 0,5 | — | — | — | — |
| 2001 | — | Q4 | — | 0,5 | — | — | — | — |
| 2000 | — | Q4 | — | 0,4 | — | — | — | — |
| 1999 | — | Q4 | — | 0,5 | — | — | — | — |
| 1998 | — | Q4 | — | 0,4 | — | — | — | — |
| 1997 | — | Q4 | — | 0,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q4 | Q4 | 299/333 |
| 2024 | ONCOLOGY | SCIE | Q4 | Q4 | 298/328 |
| 2023 | ONCOLOGY | SCIE | Q4 | Q4 | 281/322 |
| 2022 | ONCOLOGY | SCIE | Q4 | Q4 | 229/241 |
| 2021 | ONCOLOGY | SCIE | Q4 | Q4 | 235/245 |
| 2020 | ONCOLOGY | SCIE | Q4 | Q4 | 232/242 |
| 2019 | ONCOLOGY | SCIE | Q4 | Q4 | 236/244 |
| 2018 | ONCOLOGY | SCIE | Q4 | Q4 | 224/230 |
| 2017 | ONCOLOGY | SCIE | Q4 | Q4 | 218/223 |
| 2016 | ONCOLOGY | SCIE | Q4 | — | 209/217 |
| 2015 | ONCOLOGY | SCIE | Q4 | — | 207/213 |
| 2014 | ONCOLOGY | SCIE | Q4 | — | 204/211 |
| 2013 | ONCOLOGY | SCIE | Q4 | — | 196/203 |
| 2012 | ONCOLOGY | SCIE | Q4 | — | 189/197 |
| 2011 | ONCOLOGY | SCIE | Q4 | — | 174/196 |
| 2010 | ONCOLOGY | SCIE | Q4 | — | 162/185 |
| 2009 | ONCOLOGY | SCIE | Q4 | — | 148/166 |
| 2008 | ONCOLOGY | SCIE | Q4 | — | 133/143 |
| 2007 | ONCOLOGY | SCIE | Q4 | — | 126/132 |
| 2006 | ONCOLOGY | SCIE | Q4 | — | 119/127 |
| 2005 | ONCOLOGY | SCIE | Q4 | — | 114/123 |
| 2004 | ONCOLOGY | SCIE | Q4 | — | 112/123 |
| 2003 | ONCOLOGY | SCIE | Q4 | — | 109/120 |
| 2002 | ONCOLOGY | SCIE | Q4 | — | 107/114 |
| 2001 | ONCOLOGY | SCIE | Q4 | — | 98/107 |
| 2000 | ONCOLOGY | SCIE | Q4 | — | 100/103 |
| 1999 | ONCOLOGY | SCIE | Q4 | — | 95/105 |
| 1998 | ONCOLOGY | SCIE | Q4 | — | 92/104 |
| 1997 | ONCOLOGY | SCIE | Q4 | — | 96/102 |